TrademarkDir
EP
DEAD

Serial Number

90456179

Owner

Eledon Pharmaceuticals, Inc.

Attorney

Gregory B. Phillips

Filing Date

Jan 8, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

EP Trademark

Serial Number: 90456179

EP is a trademark filed by Eledon Pharmaceuticals, Inc. on January 8, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

Eledon Pharmaceuticals, Inc. (4 trademarks)

19900 MacArthur Blvd., Suite 550
Irvine, CA 92612

Entity Type: 03

Trademark Details

Filing Date

January 8, 2021

Registration Date

Not Registered

Published for Opposition

March 1, 2022

Goods & Services

Pharmaceutical products targeting selected biological pathways, namely, for the treatment of autoimmune and neurodegenerative diseases and for use in organ and cellular transplantation

Pharmaceutical research and development and medical research and development in the field of autoimmune and neurodegenerative diseases

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 15, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 15, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 22, 2024 EXRA
SOU EXTENSION 5 GRANTED
Oct 22, 2024 EX5G
SOU EXTENSION 5 FILED
Oct 22, 2024 EXT5
SOU TEAS EXTENSION RECEIVED
Oct 22, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 8, 2024 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 8, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 8, 2024 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 26, 2024 EXRA
SOU EXTENSION 4 GRANTED
Apr 25, 2024 EX4G
SOU EXTENSION 4 FILED
Apr 25, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 25, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 25, 2023 EXRA
SOU EXTENSION 3 GRANTED
Oct 23, 2023 EX3G
SOU EXTENSION 3 FILED
Oct 23, 2023 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 23, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 27, 2023 EXRA
SOU EXTENSION 2 GRANTED
Apr 25, 2023 EX2G
SOU EXTENSION 2 FILED
Apr 25, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 25, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 26, 2022 EXRA
SOU EXTENSION 1 GRANTED
Oct 24, 2022 EX1G
SOU EXTENSION 1 FILED
Oct 24, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 24, 2022 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 26, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 1, 2022 NPUB
PUBLISHED FOR OPPOSITION
Mar 1, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 9, 2022 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jan 27, 2022 PREV
ASSIGNED TO LIE
Jan 27, 2022 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 26, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 26, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 25, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 25, 2022 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 2, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 2, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 2, 2021 REAP
NOTIFICATION OF PRIORITY ACTION E-MAILED
Jul 27, 2021 GPRN
PRIORITY ACTION E-MAILED
Jul 27, 2021 GPRA
PRIORITY ACTION WRITTEN
Jul 27, 2021 CPRA
ASSIGNED TO EXAMINER
Jul 16, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 8, 2021 NWOS
NEW APPLICATION ENTERED
Jan 12, 2021 NWAP

Related Trademarks

More from this Owner

EP ELEDON PHARMACEUTICALS logo

EP ELEDON PHARMACEUTICALS

EP ELEDON PHARMACEUTICALS logo

EP ELEDON PHARMACEUTICALS

ELEDON PHARMACEUTICALS

ELEDON PHARMACEUTICALS

ELEDON PHARMACEUTICALS

ELEDON PHARMACEUTICALS

EP ELEDON PHARMACEUTICALS logo

EP ELEDON PHARMACEUTICALS

EP ELEDON PHARMACEUTICALS logo

EP ELEDON PHARMACEUTICALS